Medtronic (MDT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medtronic (MDT)

MDT 92.21

+2.4%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dennis who wrote (460)	3/3/2000 11:23:00 PM
From: Mike	Read Replies (1) of 687

This was info posted on the Yahoo board. Is this true? I would suspect it is not true. Due to the fact that no physician is going to use an easier device knowing it may fail. So what do the informed people think? Please let us know. Does the AVE MDT product have a 80% market share currently in AAA devices? Mike long-term support for Ancure by: Anne_Aorta 3/3/00 12:49 pm Msg: 5202 of 5211 As more long-term follow-up data becomes available, it is clear that GDT's non-supported one-piece implant (Ancure) is better adapting to changes in the aneurysm than MDT's fully-supported, two-piece implant (AneuRx). As the depressurized aneurysm shrinks, the AneuRx begins to bow which puts bending force on the junction in the middle of the graft. This junction occasionally dislocates which immediately repressurizes the aneurysm and can lead to a fatal rupture. This most frequently occurs at about 24 months post-op. Ancure is a compliant, one-piece graft that does not fail in this manner. Many papers have been presented at physician conferences that outline this phenomenon and FDA is examining MDT's follow-up data. Action may or may not be taken. The advantage of AneuRx is that it is far easier to implant (smaller delivery catheter and simpler deployment) and can treat more patients than Ancure. Both products are saving lives and are a far better option than the major open surgery that was once the only treatment. At the end of the day, however, patient safety is more important than physician convenience, and the GDT product is a superior implant.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next